USD10
Actions VOR
À propos de Vor BiopharmaVor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
USD10
Actions VOR
À propos de Vor BiopharmaVor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Statistiques
FENÊTRE DE TRADING
Fermé
OUVRE À
26 mars at 13:30 UTC+0
Capitalisation boursière
519,46 M $US
PRIX D'OUVERTURE
Données insuffisantes
BAS (1 an)
2,62 $US
ÉLEVÉ (1 an)
65,80 $US
BAS (24 h)
Données insuffisantes
ÉLEVÉ (24 h)
Données insuffisantes
Volume (24 h)
736,00 $US
99,9 %
Historique des prix
Time | Price | Change |
|---|---|---|
Aujourd'hui | Données insuffisantes | Données insuffisantes |
1 jour | 12,55 $US | |
1 semaine | 13,06 $US |